1 Introduction to Research & Analysis Reports
    1.1 Hospital-Acquired Infection (HAI) Diagnostic Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Hospital-Acquired Infection (HAI) Diagnostic Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Hospital-Acquired Infection (HAI) Diagnostic Overall Market Size
    2.1 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size: 2021 VS 2027
    2.2 Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market
    3.2 Top Global Hospital-Acquired Infection (HAI) Diagnostic Companies Ranked by Revenue
    3.3 Global Hospital-Acquired Infection (HAI) Diagnostic Revenue by Companies
    3.4 Top 3 and Top 5 Hospital-Acquired Infection (HAI) Diagnostic Companies in Global Market, by Revenue in 2020
    3.5 Global Companies Hospital-Acquired Infection (HAI) Diagnostic Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Players in Global Market
        3.6.1 List of Global Tier 1 Hospital-Acquired Infection (HAI) Diagnostic Companies
        3.6.2 List of Global Tier 2 and Tier 3 Hospital-Acquired Infection (HAI) Diagnostic Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size Markets, 2021 & 2027
        4.1.2 Molecular Diagnostics
        4.1.3 Blood Tests
        4.1.4 Urinalysis
    4.2 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
        4.2.1 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2021
        4.2.2 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2022-2027
        4.2.3 By Type - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2021 & 2027
        5.1.2 Urinary Tract Infections
        5.1.3 Pneumonia
        5.1.4 Surgical Site Infections
        5.1.5 Bloodstream Infections
        5.1.6 Other Hospital Infections
    5.2 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
        5.2.1 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2021
        5.2.2 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2022-2027
        5.2.3 By Application - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2021 & 2027
    6.2 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue & Forecasts
        6.2.1 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2021
        6.2.2 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2022-2027
        6.2.3 By Region - Global Hospital-Acquired Infection (HAI) Diagnostic Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
        6.3.2 US Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.3.3 Canada Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.3.4 Mexico Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
        6.4.2 Germany Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.4.3 France Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.4.4 U.K. Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.4.5 Italy Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.4.6 Russia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.4.7 Nordic Countries Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.4.8 Benelux Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
        6.5.2 China Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.5.3 Japan Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.5.4 South Korea Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.5.5 Southeast Asia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.5.6 India Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
        6.6.2 Brazil Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.6.3 Argentina Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Hospital-Acquired Infection (HAI) Diagnostic Revenue, 2016-2027
        6.7.2 Turkey Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.7.3 Israel Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.7.4 Saudi Arabia Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
        6.7.5 UAE Hospital-Acquired Infection (HAI) Diagnostic Market Size, 2016-2027
7 Players Profiles
    7.1 bioMérieux
        7.1.1 bioMérieux Corporate Summary
        7.1.2 bioMérieux Business Overview
        7.1.3 bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
        7.1.4 bioMérieux Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
        7.1.5 bioMérieux Key News
    7.2 Abbott Laboratories
        7.2.1 Abbott Laboratories Corporate Summary
        7.2.2 Abbott Laboratories Business Overview
        7.2.3 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
        7.2.4 Abbott Laboratories Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
        7.2.5 Abbott Laboratories Key News
    7.3 Alere, Inc.
        7.3.1 Alere, Inc. Corporate Summary
        7.3.2 Alere, Inc. Business Overview
        7.3.3 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
        7.3.4 Alere, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
        7.3.5 Alere, Inc. Key News
    7.4 Roche
        7.4.1 Roche Corporate Summary
        7.4.2 Roche Business Overview
        7.4.3 Roche Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
        7.4.4 Roche Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
        7.4.5 Roche Key News
    7.5 Siemens Healthcare
        7.5.1 Siemens Healthcare Corporate Summary
        7.5.2 Siemens Healthcare Business Overview
        7.5.3 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
        7.5.4 Siemens Healthcare Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
        7.5.5 Siemens Healthcare Key News
    7.6 Becton Dickenson
        7.6.1 Becton Dickenson Corporate Summary
        7.6.2 Becton Dickenson Business Overview
        7.6.3 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
        7.6.4 Becton Dickenson Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
        7.6.5 Becton Dickenson Key News
    7.7 Cepheid Inc.
        7.7.1 Cepheid Inc. Corporate Summary
        7.7.2 Cepheid Inc. Business Overview
        7.7.3 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
        7.4.4 Cepheid Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
        7.7.5 Cepheid Inc. Key News
    7.8 Thermo Fisher Scientific
        7.8.1 Thermo Fisher Scientific Corporate Summary
        7.8.2 Thermo Fisher Scientific Business Overview
        7.8.3 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
        7.8.4 Thermo Fisher Scientific Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
        7.8.5 Thermo Fisher Scientific Key News
    7.9 Seegene, Inc.
        7.9.1 Seegene, Inc. Corporate Summary
        7.9.2 Seegene, Inc. Business Overview
        7.9.3 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
        7.9.4 Seegene, Inc. Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
        7.9.5 Seegene, Inc. Key News
    7.10 Qiagen
        7.10.1 Qiagen Corporate Summary
        7.10.2 Qiagen Business Overview
        7.10.3 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Major Product Offerings
        7.10.4 Qiagen Hospital-Acquired Infection (HAI) Diagnostic Revenue in Global (2016-2021)
        7.10.5 Qiagen Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer